Fingerprint
Dive into the research topics of 'MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
F. J. Giles*, R. T. Swords, A. Nagler, A. Hochhaus, O. G. Ottmann, D. A. Rizzieri, M. Talpaz, J. Clark, P. Watson, A. Xiao, B. Zhao, D. Bergstrom, P. D. Le Coutre, S. J. Freedman, J. E. Cortes
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
59
Scopus
citations